Patent assignee · US · COMPANY

BioAtla, Inc.

🏢 View company profile →
45Patents
45Active
45Granted
54Portfolio score

Filing activity: Mar 9, 2010 → Nov 14, 2023 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8709755B2 Mirac proteins Emerging Cross-Sectional Technologies 25 Active
US9856323B2 Anti-CD22 antibodies Chemistry; Metallurgy 7 Active
US11111288B2 Conditionally active chimeric antigen receptors for modified t-cells Chemistry; Metallurgy 4 Active
US8859467B2 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Chemistry; Metallurgy 4 Active
US9637734B2 Mirac proteins Emerging Cross-Sectional Technologies 3 Active
US10513699B2 Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts Chemistry; Metallurgy 3 Active
US9464284B2 Mirac proteins Emerging Cross-Sectional Technologies 2 Active
US10106788B2 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Chemistry; Metallurgy 2 Active
US10822426B2 Humanized anti-CD73 antibodies Physics 2 Active
US11149088B2 Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereof Chemistry; Metallurgy 2 Active
US11851499B2 Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof Physics 1 Active
US11279924B2 Conditionally active polypeptides and methods of generating them Chemistry; Metallurgy 1 Active
US11254742B2 Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof Chemistry; Metallurgy 1 Active
US10047357B2 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Chemistry; Metallurgy 1 Active
US11897959B2 Anti-AXL antibodies, antibody fragments and their immunoconjugates and uses thereof Chemistry; Metallurgy 1 Active
US11584927B2 Conditionally active chimeric antigen receptors for modified T-cells Chemistry; Metallurgy 1 Active
US11472876B2 Conditionally active polypeptides Chemistry; Metallurgy 1 Active
US9994841B2 Mirac proteins Emerging Cross-Sectional Technologies 0 Active
US9982252B2 Mirac proteins Emerging Cross-Sectional Technologies 0 Active
US11859007B2 Humanized anti-CD73 antibodies Physics 0 Active
US12427347B2 Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof Physics 0 Active
US10954288B2 Modified antibody regions and uses thereof Chemistry; Metallurgy 0 Active
US11976381B2 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts Chemistry; Metallurgy 0 Active
US10697972B2 Diagnostics using conditionally active antibodies Physics 0 Active
US10562981B2 Express humanization of antibodies Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.